Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OneRF® Ablation System Post-Market Real-World Evidence Registry

NCT07546253 is registered in ClinicalTrials.gov with NeuroOne Medical Technologies Corporation as lead sponsor.

NCT NCT07546253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07546253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OneRF® Ablation System Post-Market Real-World Evidence Registry
Lead sponsor
NeuroOne Medical Technologies Corporation
Phase
Observational
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
July 31, 2028
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

drug resistant epilepsy, refractory epilepsy